EE200100153A - Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli - Google Patents

Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Info

Publication number
EE200100153A
EE200100153A EEP200100153A EEP200100153A EE200100153A EE 200100153 A EE200100153 A EE 200100153A EE P200100153 A EEP200100153 A EE P200100153A EE P200100153 A EEP200100153 A EE P200100153A EE 200100153 A EE200100153 A EE 200100153A
Authority
EE
Estonia
Prior art keywords
drug delivery
spatial control
delivery system
provides temporal
oral
Prior art date
Application number
EEP200100153A
Other languages
English (en)
Inventor
Talwar Naresh
Sen Himadri
H. Staniforth John
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/152,932 external-priority patent/US6261601B1/en
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of EE200100153A publication Critical patent/EE200100153A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100153A 1998-09-14 1999-01-19 Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli EE200100153A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,932 US6261601B1 (en) 1997-09-19 1998-09-14 Orally administered controlled drug delivery system providing temporal and spatial control
PCT/IB1999/000078 WO2000015198A1 (en) 1998-09-14 1999-01-19 Orally administered controlled drug delivery system providing temporal and spatial control

Publications (1)

Publication Number Publication Date
EE200100153A true EE200100153A (et) 2002-06-17

Family

ID=22545063

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100153A EE200100153A (et) 1998-09-14 1999-01-19 Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Country Status (40)

Country Link
EP (2) EP1281397A1 (et)
JP (1) JP2002524494A (et)
CN (1) CN1186013C (et)
AP (1) AP1659A (et)
AR (1) AR022672A1 (et)
AT (1) ATE245414T1 (et)
AU (1) AU758324B2 (et)
BG (1) BG105339A (et)
BR (1) BR9913696A (et)
CA (1) CA2343760A1 (et)
CO (1) CO5130022A1 (et)
CU (1) CU23040A3 (et)
CZ (1) CZ2001901A3 (et)
DE (1) DE69909801T2 (et)
DK (1) DK1107741T3 (et)
EA (2) EA005767B1 (et)
EE (1) EE200100153A (et)
ES (1) ES2204098T3 (et)
GE (1) GEP20043216B (et)
HR (1) HRP20010187B1 (et)
HU (1) HUP0103632A3 (et)
ID (1) ID29843A (et)
IL (1) IL141977A0 (et)
IS (1) IS5885A (et)
MX (1) MXPA01002634A (et)
MY (1) MY127952A (et)
NO (1) NO20011276L (et)
NZ (2) NZ510487A (et)
OA (1) OA11652A (et)
PE (1) PE20001058A1 (et)
PL (1) PL346798A1 (et)
PT (1) PT1107741E (et)
SI (1) SI1107741T1 (et)
SK (1) SK285478B6 (et)
SV (1) SV1999000152A (et)
TR (1) TR200100731T2 (et)
UA (1) UA73287C2 (et)
UY (1) UY25710A1 (et)
WO (1) WO2000015198A1 (et)
ZA (1) ZA995839B (et)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0204417A3 (en) * 2000-03-03 2005-03-29 Ranbaxy Lab Ltd Oral ciprofloxacin-composition of controlled release
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2006202275A1 (en) * 2000-06-26 2006-06-22 Bayer Healthcare Ag Sustained-release preparations of quinolone antibiotics and method for preparation thereof
AR030128A1 (es) * 2000-08-08 2003-08-13 Daiichi Seiyaku Co Una preparacion solida altamente absorbible
IN192748B (et) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
EP1347748A2 (en) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatic delivery system for controlled delivery of agent
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
JP2005501097A (ja) * 2001-08-16 2005-01-13 ザ ステイト オブ オレゴン アクティング バイ アンド スルー ザ ステイト ボード オブ ハイアー エデュケイション、 オン ビハーフ オブ オレゴン ステイト ユニバーシティー 膨張可能な胃内滞留装置
US6673369B2 (en) * 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
JP2005509643A (ja) * 2001-10-29 2005-04-14 ラボファーム，インコーポレーテッド 治療薬の生物学的利用能を向上させるための方法及び投薬形
KR101132969B1 (ko) * 2001-11-13 2012-04-09 아스텔라스세이야쿠 가부시키가이샤 용해성 약물 지속 방출 시스템
AU2002224011B2 (en) * 2001-11-19 2008-05-01 Lupin Limited A pharmaceutical composition for controlled release of a beta-lactam antibiotic
AU2002311622A1 (en) * 2002-04-23 2003-11-10 Lupin Limited Long acting compositions comprising zidovudine and lamivudine
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
JP2008504250A (ja) * 2004-06-28 2008-02-14 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 胃貯留特性を有する経口用徐放性テジサミル製剤。
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
GB0501810D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Chemotherapeutic formulations
WO2007000779A2 (en) * 2005-06-29 2007-01-04 Panacea Biotec Ltd. Pharmaceutical sustained release compositions and processes thereof
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form
EP2329810A4 (en) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION
WO2011125075A2 (en) 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
WO2016081593A1 (en) * 2014-11-19 2016-05-26 Fmc Corporation Nanosuspension formulation
EP3648747B1 (en) 2017-06-16 2022-09-07 Amneal Complex Products Research LLC Gastroretentive dosage forms for sustained drug delivery
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
ES2861153T3 (es) 2018-06-18 2021-10-05 Composiciones de liberación prolongada que comprenden piridostigmina
JP7034343B2 (ja) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
CN110448535A (zh) * 2019-09-04 2019-11-15 湖南宇山玉月农业科技有限公司 一种裂褶菌素胃漂浮片
CN111116794A (zh) * 2019-12-20 2020-05-08 蚌埠市鑫晟新材料科技有限公司 一种中性造纸用聚合材料的制备方法
CN115715765A (zh) * 2021-08-24 2023-02-28 江苏万邦生化医药集团有限责任公司 一种悬浮片剂
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤

Also Published As

Publication number Publication date
EP1107741A1 (en) 2001-06-20
HUP0103632A2 (hu) 2002-02-28
EP1107741B1 (en) 2003-07-23
ES2204098T3 (es) 2004-04-16
DK1107741T3 (da) 2003-11-17
WO2000015198A1 (en) 2000-03-23
PL346798A1 (en) 2002-02-25
SI1107741T1 (en) 2004-02-29
UA73287C2 (en) 2005-07-15
MXPA01002634A (es) 2002-06-04
CO5130022A1 (es) 2002-02-27
IL141977A0 (en) 2002-03-10
NO20011276D0 (no) 2001-03-13
CU23040A3 (es) 2005-04-14
EA200100346A1 (ru) 2001-10-22
CN1325299A (zh) 2001-12-05
HRP20010187A2 (en) 2002-04-30
NZ523747A (en) 2004-04-30
ZA995839B (en) 2000-03-28
AU758324B2 (en) 2003-03-20
TR200100731T2 (tr) 2001-06-21
SK3472001A3 (en) 2001-10-08
NO20011276L (no) 2001-05-10
JP2002524494A (ja) 2002-08-06
AU1779499A (en) 2000-04-03
CA2343760A1 (en) 2000-03-23
DE69909801T2 (de) 2004-06-03
AP2001002098A0 (en) 2001-03-31
EA005767B1 (ru) 2005-06-30
EP1281397A1 (en) 2003-02-05
CZ2001901A3 (cs) 2001-08-15
PE20001058A1 (es) 2000-10-05
BG105339A (en) 2001-11-30
HUP0103632A3 (en) 2005-06-28
SV1999000152A (es) 2000-07-03
PT1107741E (pt) 2003-12-31
OA11652A (en) 2004-12-08
UY25710A1 (es) 2000-03-31
EA200300847A1 (ru) 2003-12-25
HK1037967A1 (en) 2002-03-01
CN1186013C (zh) 2005-01-26
BR9913696A (pt) 2001-10-09
NZ510487A (en) 2003-04-29
IS5885A (is) 2001-03-12
ATE245414T1 (de) 2003-08-15
AP1659A (en) 2006-09-06
AR022672A1 (es) 2002-09-04
EA004443B1 (ru) 2004-04-29
MY127952A (en) 2007-01-31
SK285478B6 (sk) 2007-02-01
ID29843A (id) 2001-10-18
DE69909801D1 (de) 2003-08-28
HRP20010187B1 (en) 2004-04-30
GEP20043216B (en) 2004-04-26

Similar Documents

Publication Publication Date Title
EE200100153A (et) Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli
NO994837L (no) Intravesikal medikamentavleveringssystem
HUP9800863A3 (en) Drug delivery system for two or more active substances
EE200000546A (et) Aerosoolistatud toimeaine manustamissüsteem
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
DK1034008T3 (da) Dosisindstillende indretning til medicinske injektorer
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
EP1229962A4 (en) LASER SYSTEM FOR ENHANCED DELIVERY OF THERAPEUTIC RADIATION THROUGH A BARRIER
NO20004196D0 (no) Innretninger for legemiddelavlevering
ID28232A (id) Formulasi farmasi dengan pelepasan terkontrol
NZ513700A (en) Oral drug delivery system
EP1061987A4 (en) DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT
IL159875A0 (en) Zero order controlled drug delivery system
EP0989878A4 (en) DRUG DELIVERY SYSTEM
ZA97976B (en) Uniform drug delivery theraphy.
EP1021137A4 (en) ARRANGEMENT FOR MEDICINE DELIVERY
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
DK0984774T3 (da) Mikrosfærer med gastroretentivt reguleret frigivelse til forbedret lægemiddelafgivelse
DK1183061T3 (da) Lægemiddelafgivelsessystem
GB9905134D0 (en) Medicament delivery system
GB9923273D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB9901133D0 (en) Drug delivery system
GB9902509D0 (en) Drug delivery system
GB9700355D0 (en) Drug delivery system